RNA, Ro-associated Y1 pseudogene 13 (RNY1P13)

RNA, Ro-associated Y1 pseudogene 13 (RNY1P13) is annotated as a processed pseudogene corresponding to the RNY1 (Y RNA) gene family. Y RNAs are small non-coding RNAs known for their association with the Ro60 and La autoantigen proteins, participating in the formation of ribonucleoprotein complexes detected in rheumatologic diseases and contributing to DNA replication, RNA quality control, and cell survival under stress[3][5][1]. However, RNY1P13 itself, as denoted by the “pseudogene” designation, is a non-functional (non-protein-coding) genomic element, likely arising from retrotransposition of RNY1 RNA[4]. There is no evidence for the expression, biological function, disease association, protein product, nor therapeutic targeting of RNY1P13. As a pseudogene, it might have regulatory RNA roles typical of pseudogenes (e.g., serving as a molecular decoy in RNA networks), but such functions have not been documented for this specific locus. Accordingly, RNY1P13 is not considered a receptor, enzyme, transporter, nor a druggable or clinical target. Its clinical and pharmacological significance is currently null. Notes: - This query does not pertain to a canonical molecular target but to a pseudogene, so both therapeutic relevance and structured target data are absent[4]. - Most literature and database entries focus on functional Y RNA gene family members, not on their pseudogenes[3][5][1]. - No drugs, biomarkers, nor safety data are associated with RNY1P13. If more information on the Y RNA family or on the active RNY1 gene is needed (rather than this pseudogene), indicate this for expanded context.

Other names

RNY1 pseudogene 13RNY1P13RNA, Ro-associated Y1 pseudogene 13